Summary.-In vivo growth characteristics of myeloid leukaemia induced by wholebody irradiation of CBA/H male mice were examined in the strain of origin by procedures expected to enhance or depress immunological responses. Syngeneic growth in vivo (survival time and frequency of takes) was not modified by attempted active immunization with radiation-inactivated cells or by sublethal whole-body irradiation of recipients before inoculation of small numbers of clonogenic cells. Since the growth stimuli involved in in vivo repair of severely damaged normal haemopoietic tissue also did not modify the growth of the radiation-induced leukaemia cells in syngeneic passage, their growth in vivo in the irradiated primary hosts can be regarded as autonomous by the stage at which leukaemia was diagnosed. Challenge inocula in the "immunization" experiments were 1-9 clonogenic cells from 4 different passaged lines and in the whole-body radiation experiments, 1-103 clonogenic cells derived from 11 different primary hosts and 4 different passaged lines.
FOR MORE THAN A DECADE a commonly held hypothesis underlying the treatment of malignant disease has been that once the number of malignant cells in the host has been sufficiently reduced by active treatment (surgery, ionizing radiation, chemical agents) the few remaining viable cells can and will all be killed by the body's natural defences, especially its immunological responses (Denoix & Mathe, 1979) . The prime experimental evidence came from studies of L1210 leukaemia, a longmaintained cell line which originated in methylcholanthrene-treated DBA/2 mice more than 30 years ago, and was transplanted into a compatible hybrid (C57-BL/6 x DBA/2)F1 (Mathe, 1968; Mathe et al., 1969) . However, the experimental end-point was primarily prolongation of survival, not disappearance of the leukaemia, and the demonstration of an immunological response to L1210 in F1 hybrids between the strain of origin and other mouse strains (Glynn et al., 1963) may suggest that the experimental model was not wholly satisfactory.
Since myeloid leukaemia can be regularly induced in CBA/H male mice by single brief exposures to X-rays, y-rays or fission neutrons over a wide range of doses (Major & Mole, 1978; Mole & Davids, 1980, and unpublished) an alternative model is available for examining questions about the survival and behaviour of small numbers of malignant cells in vivo. Attempted active "immunization" and damage to the immune system have been shown to have no effect, as already noted (Meldrum & Mole, 1981 Gy/min in a plastic container. Three such injections from succeeding but non-consecutive passages of a given line were made into male CBA/H mice, beginning at 60 days of age and then at intervals of 3-6 weeks. Challenge with small numbers of viable leukaemia cells was delayed until 6-10 weeks after the third immunizing injection, to avoid possible confusion by leukaemia originating from cells in the immunizing injections which had escaped inactivation by irradiation. At the outset, before immunization was attempted, pairs of male mice from 5 litters were selected at random, one of each pair to be immunized, the other to be an unimmunized control. They were challenged with the same cell inoculum. Because of the time required for the immunizing procedure, challenge was at 120-160 days of age.
Whole-body irradiation of mice 24 h before inoculation with living leukaemia cells was with 250 kVp X-rays at -0-5 Gy/min.
The viscera of every dead or dying mouse were examined macroscopically to verify that leukaemia was grossly evident. The spleen was enlarged 5-20-fold, uniformly and without circumscribed foci, usually pink or greypink or with brown-green flecks. The liver was uniformly enlarged, but macroscopically not obviously infiltrated. Lymph nodes, peripheral and central, and thymus were not enlarged, except that occasionally cervical nodes were 2-3-fold normal in size, and sometimes pale green. The depth of colour of the sternal marrow and the degree of anaemia were variable. In the experiments reported. there was never anv doubt about the cause of deaths within 150 days. Later deaths sometimes needed histological study, particularly when lymphoid leukaemia needed to be excluded. The macroscopic changes were evident but much less conspicuous in deaths following inoculation of cells from multipassaged lines.
Mice surviving 300 days after challenge or at 200 days after the most delayed positive take, whichever was the later, were killed and examined to confirm the absence of leukaemia.
RESULTS

Grafting of myeloid leukaemia cells
Myeloid leukaemia has not been observed in over 500 unirradiated controls and, apart from grafted cases, has occurred only in suitably irradiated mice, the primary hosts. One million or more myeloid leukaemia cells taken from the spleen of a freshly killed primary host and inoculated i.v. have not failed to take in 30 attempts. Even when the spleen cells were obtained a number of hours after natural death, the probability of take seemed to be high. Serial dilution of a spleen-cell suspension commonly, but not invariably, gave a linear relationship between survival time and log (number of cells injected i.v.) ( Figure) . This is what would be predicted from the simplest possible pair of assumptions, that death occurs when the number of leukaemia cells in the body reaches a given value, independently of the number injected, and that after i.v. injection the leukaemia cells Table III , footnotes § and i). When serial inoculations were made, and at a using as the source of the cells on each the slope of occasion the spleen of an animal which had asure of the received a large number of leukaemia nogenic cells cells, there was a progressive change in growth properties during the first passages requency of (Figure) . The survival time for a given r of injected number of injected cells decreased, and so a Poissonian did the minimum number of cells required ward, there-for a take; i.e., the clonogenic fraction ,ervations on increased. Such a progressive change in f cells which cellular properties was not seen regularly vould fail to when spleen cells were cloned in vivo by This corres-successive inoculation of the minimum ie clonogenic effective number of cells, but experiments volume. The of this kind are not described here. The effective number of truly clonogenic cells in an inoculum of 10 cells was calculated from the frequency of leukaemia takes in the non-immunized mice, and varied from 0 3 to 9 (Table I) .
The dose of 30 Gy to 3 successive "immunizing" cell suspensions was insufficient to kill every clonogenic cell of 3 of the 4 leukaemia lines. Thus each of the 4 lines was examined using 50 Gy, and only one (line XVI) with 30 Gy also.
TVhole-body irradiation of recipients
Five male CBA/H mice which had received 0, 2, 4 or 6 Gy whole-body X-irradiation the day before were given the same i.v. injection of unirradiated spleen cells from leukaemic mice. Cells from 11 primary hosts and from 3 multiply passaged lines were used. Table II gives the survival times of unirradiated and irradiated mice when the inoculum from a primary host was more than sufficient to kill every recipient with myeloid leukaemia. In 6/7 cases it was clear that prior irradiation of the recipient mice had no influence on survival time. With cells from primary host XIX, the mean survival time was slightly but significantly shorter in the irradiated mice. (Table II) . In 2 of the 4 experiments with minimal numbers of clonogenic cells from primary hosts (Table III) , the survival time results were straightforward (XXVII and XXVIII) but in the other 2, mean survival time may provide an inadequate summary. Cells from host XXXI gave an exceptionally wide range of survival times for mice developing leukaemia, whether they had been irradiated or not (Table  III) . For XXX cells there were only 3 leukaemia takes for assessment. The survival time of the unirradiated recipient at 90 days was much shorter than the 226 and 304 days of the 2 takes in irradiated recipients (one after 4 Gy, one after 6 Gy). Overall it seems clear, however, for both primary and passaged myeloid leukaemia cells, that whole-body irradiation did not systematically augment or accelerate the growth of i.v. injected syngeneic cells, even when minimum numbers of clonogenic cells were given.
One methodological problem in interpreting delayed takes in recipients irradiated before inoculation is that whole-body irradiation is itself leukaemogenic. Amongst over 100 cases of leukaemia so caused by single brief exposures to X-rays in the range 1 5-6 Gy, 11 (Table III) .
DISCUSSION
There are many reports of occasional cases of myeloid leukaemia in groups of laboratory animals treated by a variety of agents, and presumably induced by them but, up to the present, systematic and reproducible induction has been only by ionizing radiation. The first report (concerning irradiated RF mice), was over 40 years ago, and subsequently extensive observations were reported by Upton and his colleagues in the 1950s and 1960s. The disease closely resembled chronic granulocytic leukaemia in man . The RF mice were not inbred (Robinson & Upton, 1978) and grafting of myeloid leukaemia cells within the strain, even using very large numbers, was not always successful, even after 23-27 passages (Wald et al., 1964) . In several respects, this contrasts with our observations on highly inbred CBA/H mice, in which the clinical course and cellular characteristics resemble acute myeloid leukaemia, there is a very low level of the natural disease in unirradiated controls, and syngeneic grafting is straightforward.
It is never possible to provide a conclusive experimental demonstration of the absence of a phenomenon. The evidence presented is the failure to modify the in vivo growth characteristics of radiationinduced myeloid leukaemia cells by procedures which should enhance or depress immune responses. Enhancement was attempted by inoculation of large numbers of cells irradiated to prevent their division but not so as to produce immediate and drastic necrosis. Depression of immune responses was by whole-body irradiation at about 1 1 or 4 LD50. The testing procedures were designed to maximize the chance of demonstrating any natural or acquired tumour resistance, by using the smallest possible number of inoculated clonogenic cells, and were all done in a syngeneic situation, to minimize the chances of false positive results. It seems fair to conclude that if the myeloid leukaemia cells are immunogenic in vivo, they are very weakly so.
The failure of prior sublethal wholebody irradiation to modify the growth characteristics of the myeloid leukaemia cells in vivo must also mean that these cells did not respond to the growth stimuli responsible for the rapid repair of radiation-damaged normal haemopoietic tissue which is so characteristic a sequel of sublethal whole-body exposure. Comparison of irradiated and unirradiated recipients can be regarded as a test for autonomy of growth of the inoculated cells. By such a test the myeloid leukaemia cells used (i.e., within a few days of diagnosis in the primary host) seem truly autonomous. It remains an open question whether this autonomy develops progressively during the "latent interval" between irradiation and diagnosis or is one aspect of the initial transformation of a postulated haemopoietic stem cell into a leukaemia "mother cell".
An-apparently variable capacity for growth in a syngeneic host of individual clonogenic cells from the spleen of a primary host can be demonstrated, at least sometimes, when the mean number of effective clonogenic cells in an injection volume < 1 (cf. Table III ). There could be a variety of causes, environmental (e.g. the chance of a single cell arriving in one micro-environment rather than another in the injected animal) or intrinsic (e.g. differences between the genome of different cells which can be revealed only when competition between them can be avoided). The experiments reported here clearly throw little light on such questions.
A "natural immune resistance to neoplastic tissue elements" has been demonstrated in many virally and chemically induced malignancies and in some UVinduced, but remarkably little has been published dealing with tumours induced by ionizing radiation. A large systematic experiment with radiostrontium-induced osteosarcomas, using transplantation into syngeneic recipients previously injected with large numbers of heavily irradiated tumour cells and/or given whole-body irradiation, was interpreted as indicating specific transplantation antigens in the osteosarcomas (Nilsson et al., 1972) but this interpretation can be questioned. Differences were not evident over the whole range of cell inocula, and the basis for the analysis was a quite unusual postulate for the relationship between number of tumour cells inoculated and the take frequency, based not at all on biological considerations but simply on a statistical need for linearity; viz., an arc-sine transformation of the square root of take frequency against log (cell number).
The evidence provided here about radiation-induced myeloid leukaemia is more simply interpretable, and the observation that a regularly reproducible radiation-induced malignancy seems not to be immunogenic may therefore be of interest. Clearly more examples are required for confirmation, not only for myeloid leukaemia but also for other radiation-induced tumours. Even so, as they stand, the findings are in close agreement with the failure to demonstrate a natural defence mechanism against spontaneous tumours (Hewitt et al., 1976) and may be regarded as providing supplementary support for these workers' conclusion that ". . . practically all the animal data presented in support of a general theory of tumour immunogenicity ... have been obtained from transplanted systems which entail artefactual immunity associated with viral or chemical induction of the tumours or their allogeneic transplantation".
The intrusion of allogeneic phenomena is illustrated in the observations that myeloid leukaemia cells originating in the RFM/UN strain (from Oak Ridge) did not grow in unirradiated RF mice referred to as RFJ (from the Jackson Laboratory) (Husseini et al., 1976) and that they increased exponentially only for a limited period in mice referred to as RF/J (coming from Japan) (Tanaka et al., 1970) .
Other reports of the immunogenicity of myeloid leukaemia cells cannot be fully assessed because ofinadequate information on the genetic compatibility of cells and the recipients into which they were transplanted. No evidence of resistance to grafts of 106 viable RFM/UN leukaemia cells was found in RFM/UN mice which had been given injections of heat-treated cells of the same origin, but nothing was said about how the originally non-inbred mice had been maintained in the decade before the experiments were done (Adler & Trobaugh, 1978) . If immunogenicity was detected for the BNML myeloid leukaemia in Brown Norway rats, it was very weak (Hagenbeek, 1977) and BNML is another line of leukaemia cells which has been maintained by passage for many years in different laboratories and used in animal strains given the same designation but not necessarily with the same genetic constitution.
Myeloid leukaemia in a truly inbred strain of laboratory animal allows less equivocal experimental investigation of possible natural defences against very small numbers of malignant cells ("minimal residual disease") than most experimental models used hitherto. Single-cell suspensions can be prepared very simply from primary hosts, allowing quantitative experiments to be done without the need for potentially damaging procedures for tissue disruption, or for preliminary serial passaging in order to derive cell lines with reproducible growth characteristics but with the concomitant and inescapable selection of only those lines that continue to grow and only those cells that divide fastest. No adjuvant procedure is required to enable small numbers of cells to take. Results are interpretable without reference to the development of a blood supply to a local tumour mass. "Transplantable animal tumours or long passage in vitro tumour cell lines may not accurately reflect the proliferative behaviour of the small compartment of tumour stem cells of an individual . . . primary cancer" (Salmon, 1979) . Furthermore, the CBA/H myeloid leukaemia cells can be maintained and/or experimented with in vivo in a truly syngeneic environment (as if they were continuing to grow in their primary host) avoiding extraneous and possibly misleading immunogenetic influences. It is also easy in practice to use a number of different primaries in any given investigation, so improving the validity of any conclusions that may be drawn.
It is, of course, true that most malignant disease is in the form of a solid tumour with a specific blood supply. However, if it is granted that the only fundamental difference between myeloid leukaemias and solid cancers lies in the need, or lack of it, for a structural component, then more may be learnt about the specific properties of the structural component if an example exists where its influence does not need to be taken into account when investigating the properties of malignant cells as such.
